Ignite Creation Date:
2024-05-06 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04704323
Status:
RECRUITING
Last Update Posted:
2024-02-15
First Post:
2020-12-21
Brief Title:
CAP-100 for Subjects With RelapsedRefractory Chronic Lymphocytic Leukemia
Sponsor:
Organization:
Catapult Therapeutics